MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Dystonia: Treatment"

  • 2024 International Congress

    Treatment of Craniofacial Dystonias with Methylphenidate: A Case Series.

    R. Lopez-Castellanos, H. Jinnah, M. Thayani (Atlanta, USA)

    Objective: To determine benefit from using methylphenidate for patients with uncontrolled blepharospasm and/or oromandibular dystonia. Background: The preferred treatment for blepharospasm and related craniofacial dystonias…
  • 2024 International Congress

    Istradefylline therapy for dystonia in Parkinson’s disease

    NAO. Kanzato, KOH. Nakachi, SAT. Mochizuki, (Okinawa, Japan)

    Objective: To clarify the basal ganglia network links between PD and Dystonia in PD (Dys-PD) co-occur, and to get the conceptually novel pharmacotherapy. Background: Dys-PD is one…
  • 2024 International Congress

    Rapid Onset Kinematic Effects of Thalamic/Subthalamic DBS in Cervical Dystonia

    T. Hart, A. Sadnicka, I. Cociasu, L. Ricciardi, F. Baig, M. Hart, M. Edwards, E. Pereira, F. Morgante (London, United Kingdom)

    Objective: To assess the acute effect of combined ventrolateral thalamus (VL-Th) and subthalamic nucleus (STN) stimulation in Cervical Dystonia (CD) on clinical and kinematic measurements…
  • 2024 International Congress

    Paroxysmal non-kinesigenic dyskinesia: atypical neurological presentation of Lyme neuroborreliosis

    I. Sarac, H. Sarac, F. Borovecki, Z. Kresic (Zagreb, Croatia)

    Objective: To describe unusaul case of paroxysmal non-kinesigenic dyskinesia due to Lyme neuroborreliosis in a elderly female patient. Background: Nervous system Lyme disease is common…
  • 2024 International Congress

    One-Year Outcomes of Multitarget Thalamic and Pallidal Deep Brain Stimulation in Unilateral Dystonia

    J. Altamirano, K. Salinas-Barboza, A. Armas-Salazar (Mexico City, Mexico)

    Objective: This study presents the one-year outcomes of two patients who underwent unilateral deep brain stimulation (DBS) targeting the thalamic nuclei ventralis intermedius and ventralis…
  • 2024 International Congress

    A Phase IIb Double-Blind Placebo-Controlled Randomized Cross-Over Clinical Trial of Sodium Oxybate in Isolated Focal Laryngeal Dystonia

    L. O'Flynn, A. Hamzehei Sichani, S. Frucht, A. Rumbach, N. Sharma, P. Song, A. Worthley, K. Simonyan (Boston, USA)

    Objective: A phase IIb double-blind, placebo-controlled, cross-over, randomized clinical trial of a single dose of sodium oxybate investigated the efficacy and safety of the drug…
  • 2024 International Congress

    Clinical Outcomes and Local Field Potential Characteristics in Bilateral GPi DBS in 2 cases of X-Linked Dystonia Parkinsonism

    E. Donlon, C. O'Keefe, G. Mullane, F. Ruggieri, M. Alexander, C. Moran, T. Lynch, C. Fearon, E. Pereira, R. Walsh (Dublin, Ireland)

    Objective: We describe clinical outcomes and local field potential characteristics in 2 cases of fulminant onset XDP who went on to have bilateral GPi DBS…
  • 2024 International Congress

    Pregnancy in Dystonia or Tourette’s patients with DBS. Eleven New Cases and a Review of the Literature.

    R. Mehanna, A. Tarakad, L. Taneff, E. Furr Stimming (Houston, USA)

    Objective: To review the available literature on pregnancy in patients who have received deep brain stimulation (DBS) for dystonia or Tourette’s syndrome (TS). Background: DBS…
  • 2024 International Congress

    DystoniaDBSNet: A novel deep learning biomarker of predictive treatment outcomes in dystonia

    DR. Yao, N. Sharma, K. Bhatia, E. Mulroy, J. Wong, Y. Yu, H. Akram, T. Foltynie, P. Limousin, L. Zrinzo, K. Simonyan (boston, USA)

    Objective: To develop an objective predictive measure of deep brain stimulation (DBS) treatment outcomes in dystonia. Background: Dystonia causes involuntary muscle contractions, affecting movements and…
  • 2024 International Congress

    DYT-KMT2B generalized dystonia managed with GPi-DBS

    A. Santana, A. Azzoni, M. Sakuma, F. Godinho, E. Barbosa, C. Gusmão, R. Cury (São Paulo, Brazil)

    Objective: The phenotypic spectrum in dystonic syndromes in childhood is wide. Mutations in KMT2B gene were first described in 2016 and it means mutations in…
  • « Previous Page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • 39
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • #28970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley